Search results
In $270M National Settlement, Generic Opioid Maker Will Supply Overdose Reversal Pill, Cash | New...
Law.com· 24 hours agoAmneal Pharmaceuticals will pay California, New York and four other states more than $272 million in...
Scant drug ingredients linked to US generic-drug shortages in first 2 COVID years
Center for Infectious Disease Research and Policy· 3 days agoCopied to clipboard In the first 2 years of the COVID-19 pandemic, shortages of 11% of generic...
FTC Moves to Allow Generic Versions of Ozempic
Futurism via Yahoo Finance· 1 day agoThe Federal Trade Commission is seeking to clear the path for generic Ozempic — but there will be a long road ahead before cheaper versions of the...
California cuts cost of overdose-reversal drug by 40% in generic deal - The Boston Globe
The Boston Globe· 5 days agoCalifornia is stepping up efforts to combat surging opioid-related deaths by teaming with a maker of...
California will supply first responders, universities with opioid overdose reversal drug for free
LA Times via Yahoo News· 5 days agoLast week, the FDA approved the generic version of Narcan spray made by Amneal Pharmaceuticals....
Coach's death spotlights pharma's profit wins in chemo drug shortage
Salon via Yahoo News· 1 day agoCongress could change that at any time — but does not. As reported by NBC News in May 2023, US Food...
Novo Nordisk To Slash Prices On Buzzy Drugs Ozempic and Wegovy
Futurism via Yahoo Finance· 1 day agoNovo Nordisk, the Danish maker of the injectable diabetes drug Ozempic and its sister weight-loss...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 4 days agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 4 days agoAt issue is what is called the Orange Book, a document published by the Food and Drug Administration...
Lawsuit accuses Boehringer Ingelheim of false patent listings
Hartford Business Journal· 2 days agoA lawsuit filed in federal court in Connecticut accuses Boehringer Ingelheim Pharmaceuticals Inc. of...